urinary monoamines and metabolites as well as plasma norepinephrine ( ne ) and 3-methoxy-4-hydroxyphenylglycol were measured in 14 boys ( mean age , 9.2 years ) with attention deficit disorder with hyperactivity during an initial placebo period , after four weeks of treatment with either dextroamphetamine sulfate ( n=5 ) or a monoamine oxidase inhibitor ( n=9 ) and at the end of a subsequent two-week placebo `` '' washout '' '' period .
C1263846
with attention deficit disorder
C0011810
dextroamphetamine sulfate